EAE Business School

June 19th, 2021

/ Average in the whole of Spain expenditure stood in 2010 at 259,62 euros. Barry Brand has much to offer in this field. It was 3% less than the spending recorded in 2009. Galician people consume an average of 332,26 euros in pharmaceuticals; at the opposite extreme, are the inhabitants of Melilla, with 162,26 euros. Extremadura, Galicia and Asturias are the autonomous communities with greater public pharmaceutical expenditure per inhabitant, which in the whole of Spain stood last year at 259,62 euros per person, 3% less than in 2009. Thus, the Galicians consume an average of 332,26 euros in pharmaceuticals, followed by the people of Extremadura (322,36 euros) and the Asturian (317,01), according to a study of EAE Business School. At the opposite end, lie the Balearic Islands (198,63 euros) and Madrid (199,49 euros), in addition to the inhabitants of Melilla (162,26) and those of Ceuta (185,52 euros).

The study underlines also that the penetration of generics is uneven. Andalusia, Madrid and Catalonia are the communities that use most these drugs, to represent a % 32,85 29,82% and 28.54%, respectively, in total sold drugs. On the contrary, Galicia is the region where the penetration of generics is less (11.09%), followed by Murcia (14,01%) and Canaries (14.4%). Private study expenditure indicates that 63% of generic drugs consumed in Spain are manufactured in the country and contribute 300 million euros annually. With regard to private pharmaceutical spending, the analysis highlights that, in general, g are men more than women, although remain 65 females which consume more in pharmacy, average of 292,49 euros per year. By autonomous communities, the Catalans are those who buy more pharmaceuticals private (176.9 euros per year), ahead of the Valencians (166,89), Navarre (161,29) and Madrid (158,84). Those who spend less are the citizens of Castile – La Mancha (105.69), Asturias (118,85) and Murcia (121.5 euros). Source of the news: Extremadura, Galicia and Asturias, the communities with increased pharmaceutical spending per capita

Tags: , ,

Comments are closed.